2,317 followers
Ophthopedia Update: One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents https://t.co/ugtiZNUMx2 #Ophthomology #Eye #Ophthotwitter https://t.co/D3K2cjttEW